“Article: Highlights in breast cancer” has been added to your cart. View cart

Article: P18 Ibrutinib, the first available BTK inhibitor: single centre experience

€2.42

SKU: product-article-15297 Category: General

Description
Reviews (0)

Description

P18 Ibrutinib, the first available BTK inhibitor: single centre experience

Reviews

There are no reviews yet.

Be the first to review “Article: P18 Ibrutinib, the first available BTK inhibitor: single centre experience”

Top

Article: P18 Ibrutinib, the first available BTK inhibitor: single centre experience

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in digestive oncology